Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check14 days agoChange DetectedThe web page has been updated to include new drug information for Cemiplimab and additional cancer-related resources, while some previous location details and specific cancer types have been removed.SummaryDifference12%
- Check21 days agoChange DetectedThe page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.SummaryDifference1%
- Check28 days agoChange DetectedThe study has transitioned from a recruiting status to an active status, and the number of locations has decreased from 11 to 10. Additionally, the last update date has been revised to August 15, 2025.SummaryDifference6%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.8%
- Check42 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.